Oblique Therapeutics
0 followers
‌
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.
Industries
+2
Headquarters
Employees
Links
Org chart
Christer Nordstedt
Collapse
Olof Larsson
CSO
Kjell Andersson
Head of Medicinal Chemistry
Marie Scherlund
Chief Operating Officer
Mats Lindskog
Chief Business Officer
Hans-Peter Ostler
Styrelseledamot
